Accordingly, high SLAMF6 levels are a surrogate indicator for immune-favorable tumor microenvironments of breast cancer and melanoma; SLAMF6high tumors are significantly enriched with gene expression patterns associated with T cell activation and effector functions [37]. The gene discussed is SLAMF6; the disease is breast cancer.